Laboratory-developed Testing Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2022 and is forecast to a readjusted size of USD 4649.1 million by 2029 with a CAGR of 3.6% during review period.

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.

LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.

While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.

The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market. North America is the largest market with more than 65% of the market, followed by Europe with about 15%.

This report is a detailed and comprehensive analysis for global Laboratory-developed Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Laboratory-developed Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Laboratory-developed Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Laboratory-developed Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Laboratory-developed Testing market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Laboratory-developed Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Laboratory-developed Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
 

   Adaptive Biotechnologies Corporation
   Quest Diagnostics
   Roche
   Illumina
   Qiagen
   Eurofins
   Guardant Health
   Biotheranostics
   Adaptive Biotechnologies
   Rosetta Genomics
   Biodesix
   Helix

   Commercial Service
   R&D

   Genetic Testing
   Oncology
   Infectious Disease
   Others

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the Laboratory-developed Testing Market in 2025?

Laboratory-developed tests (LDTs) offer high flexibility and customization for specific patient needs. They allow healthcare providers to adapt quickly to emerging diseases and diagnostic requirements. Additionally, LDTs often come with lower costs compared to commercial tests, which can make them more accessible for healthcare systems.

How does the Laboratory-developed Testing Market face challenges?

The lack of standardization and regulatory oversight for LDTs presents significant risks. Without clear guidelines, there can be concerns regarding the accuracy and reliability of results, potentially leading to misdiagnoses. Furthermore, the increasing regulatory scrutiny, especially from bodies like the FDA, might restrict the development and expansion of LDTs.

What opportunities exist in the Laboratory-developed Testing Market in 2025?

The rise in personalized medicine and precision healthcare creates significant opportunities for LDTs. As demand for tailored treatments grows, LDTs are poised to play a key role in disease detection and monitoring. Additionally, with advancements in molecular diagnostics and genomics, the potential for innovation in LDTs is vast.

What are the threats to the Laboratory-developed Testing Market in 2025?

The growing regulatory pressure, especially with new healthcare policies, may lead to restrictions that could limit market growth. Additionally, competition from large diagnostic companies with more robust resources may make it challenging for smaller laboratories to thrive. The risk of technological obsolescence is also high as newer, more advanced testing methods are introduced.

What are the political factors impacting the Laboratory-developed Testing Market in 2025?

The political landscape heavily influences the regulatory environment for LDTs. Increased government scrutiny and potential changes in healthcare policies, such as stricter FDA regulations, could either enable or hinder market growth. Political decisions on funding for healthcare systems and diagnostic innovations also play a role in shaping the market's trajectory.

How does the economic environment affect the Laboratory-developed Testing Market?

The economic factors, such as healthcare budgets and reimbursement rates, directly impact the affordability and adoption of LDTs. In economically challenging times, healthcare systems may prioritize cost-effective solutions, driving demand for more affordable LDTs. Conversely, economic growth could stimulate investment in more advanced testing technologies, fostering innovation in the sector.

What social factors influence the Laboratory-developed Testing Market?

The increasing consumer demand for personalized healthcare and precision medicine is a key social factor driving the LDT market. Public awareness about genetic testing, chronic diseases, and early diagnosis is also contributing to the market's growth. Additionally, demographic shifts, such as aging populations, fuel the need for more specialized and tailored diagnostic tests.

How do technological advancements impact the Laboratory-developed Testing Market?

Technological innovation is the core driver for laboratory-developed tests. Advances in molecular diagnostics, genomics, and AI-powered analysis allow for more accurate and faster testing, expanding the scope of LDTs. These technologies enable laboratories to stay competitive by offering cutting-edge tests that cater to evolving medical needs, including rare diseases and complex conditions.

What environmental factors influence the Laboratory-developed Testing Market?

Environmental concerns, like reducing medical waste and improving sustainability in diagnostic procedures, could impact the LDT market. There's growing pressure on laboratories to adopt eco-friendly practices, such as minimizing single-use plastics and ensuring proper disposal of biological samples. These environmental considerations could shape the development and adoption of laboratory tests in the future.

What legal factors affect the Laboratory-developed Testing Market?

LDTs face increasing legal challenges related to regulatory compliance, intellectual property, and liability. As governments tighten regulations on medical devices and diagnostics, laboratories must navigate complex legal frameworks to stay compliant. Additionally, concerns about data privacy, particularly related to genetic testing, could trigger new legal standards for the protection of patient information.

Who are the suppliers in the Laboratory-developed Testing Market in 2025?

Suppliers in this market include manufacturers of diagnostic reagents, laboratory equipment, and genetic sequencing technologies. Other suppliers include software providers for data analysis, as well as the regulatory bodies that establish standards for testing. Additionally, research institutions that provide innovations and advancements in testing methodologies play a key role.

What inputs are required for the Laboratory-developed Testing Market?

Inputs consist of high-quality raw materials like reagents, test kits, and biological samples. Data from clinical research and diagnostic guidelines also serve as essential inputs. Furthermore, laboratory infrastructure, skilled personnel, and advanced technologies such as genomics platforms and AI-driven analysis tools are critical components of the testing process.

What processes are involved in the Laboratory-developed Testing Market?

The main processes include research and development of new testing methods, regulatory approval, and the actual test development. This is followed by laboratory testing, data analysis, and interpretation of results. Quality assurance processes, including validation and compliance checks, are critical to ensure the reliability of the tests. Post-testing, there is also a process for reporting results to healthcare providers or patients.

Who are the customers in the Laboratory-developed Testing Market?

The customers include healthcare providers, hospitals, diagnostic laboratories, pharmaceutical companies, and research institutions. Additionally, individual patients or consumer markets for direct-to-consumer genetic tests also represent a growing customer base, especially for personalized health testing.

What are the outputs in the Laboratory-developed Testing Market?

The primary outputs are the laboratory-developed tests themselves, which are diagnostic tools tailored for specific medical conditions. These outputs also include the associated data reports, which provide insights into a patient’s health status, genetic markers, or disease progression. Additionally, innovation and new methodologies developed in the course of testing become an output for future applications.

What is the threat of new entrants in the Laboratory-developed Testing Market in 2025?

The threat of new entrants is moderate. While barriers to entry, such as the need for specialized knowledge and laboratory infrastructure, can be high, advancements in technology and reduced regulatory hurdles in some regions might allow smaller labs or startups to enter the market. However, established players with strong reputations and regulatory approval still hold a significant competitive edge.

How intense is the rivalry among existing competitors in the Laboratory-developed Testing Market?

Rivalry among existing competitors is high. The market is becoming increasingly crowded with both traditional diagnostic companies and innovative smaller labs offering customized solutions. The growing demand for personalized medicine and precision healthcare has intensified competition, pushing companies to innovate continuously and improve the accuracy, speed, and affordability of their tests.

What is the bargaining power of suppliers in the Laboratory-developed Testing Market?

The bargaining power of suppliers is moderate. While some key suppliers, such as those providing unique reagents or advanced sequencing technologies, may hold significant power due to their specialized products, laboratories can often switch between suppliers or develop their own solutions to mitigate reliance. However, any disruption in the supply of essential materials could impact test development.

What is the bargaining power of buyers in the Laboratory-developed Testing Market?

The bargaining power of buyers is moderate to high, particularly for large healthcare providers, hospitals, and diagnostic labs that can negotiate prices or select from a range of testing options. However, as demand for specialized tests rises, individual patients—especially in the consumer health sector—are often less price-sensitive, as they are seeking specific, tailored tests and diagnostic insights.

What is the threat of substitute products or services in the Laboratory-developed Testing Market?

The threat of substitutes is moderate. Alternative diagnostic methods, such as point-of-care tests, over-the-counter genetic testing, or advances in imaging technologies, could serve as substitutes to laboratory-developed tests. However, LDTs are often more precise and can cater to more specific needs, making them irreplaceable in certain healthcare scenarios, especially in personalized medicine.

What are the key raw materials and components needed for the Laboratory-developed Testing Market in 2025?

Key raw materials include reagents, biological samples, and chemicals necessary for testing and analysis. Additionally, components such as lab equipment (e.g., microscopes, PCR machines, and sequencing platforms) and specialized software for data analysis and interpretation are vital for the development and execution of LDTs.

How does technology affect the upstream factors in the Laboratory-developed Testing Market?

Technology plays a significant role in upstream processes, particularly in the development of testing platforms and diagnostic tools. Advances in genomics, molecular biology, and artificial intelligence influence the design of more accurate and faster tests. Additionally, improvements in lab automation and data analytics reduce costs and improve efficiency, making the supply chain more effective.

What role do suppliers play in the upstream factors of the Laboratory-developed Testing Market?

Suppliers are crucial in providing the essential materials, tools, and technologies needed for test development. They supply reagents, consumables, and equipment necessary for labs to produce accurate and reliable tests. The quality, cost, and availability of these supplies directly impact the speed of innovation and the overall cost of LDTs.

What impact does regulation have on the upstream components of the Laboratory-developed Testing Market?

Regulations play a critical role in shaping the upstream market by influencing the standards and certifications required for reagents, equipment, and technologies. Regulatory bodies like the FDA or local health authorities set requirements for quality control, safety, and efficacy of testing components, which can impact both the cost and availability of supplies for laboratories.

How does the availability of skilled labor affect the upstream dynamics in the Laboratory-developed Testing Market?

The availability of skilled labor, including laboratory technicians, researchers, and data analysts, is essential to the upstream processes. As LDTs become more specialized, the demand for highly skilled personnel in genomics, bioinformatics, and molecular biology increases. The shortage of such talent could slow down innovation and increase operational costs for labs.

What are the key processes involved in the midstream phase of the Laboratory-developed Testing Market?

The midstream phase primarily involves test development, validation, and commercialization. This includes adapting laboratory protocols, refining diagnostic techniques, ensuring quality control, and complying with regulatory requirements. It also involves the integration of technologies like molecular diagnostics, sequencing tools, and AI for data analysis, followed by clinical trials to validate test accuracy and reliability.

How do laboratories manage the flow of materials and resources during the midstream phase?

Laboratories manage the flow of materials through a carefully structured supply chain. They ensure timely procurement of reagents, consumables, and test kits while maintaining proper inventory levels. Coordination with suppliers and logistical planning is key to ensuring that tests can be developed and commercialized without delays, especially when dealing with perishable or time-sensitive components like biological samples.

What role does quality control play in the midstream phase of the Laboratory-developed Testing Market?

Quality control is a crucial part of the midstream phase. It ensures that laboratory-developed tests meet the required standards for accuracy, reproducibility, and safety. Laboratories conduct rigorous validation and verification of test results, often through proficiency testing and clinical trials, to ensure the reliability and consistency of the tests before they are introduced to the market.

How does innovation impact the midstream phase in the Laboratory-developed Testing Market?

Innovation drives continuous improvements in testing methodologies, from the development of more accurate assays to the integration of advanced technologies like AI and machine learning for result interpretation. These innovations can lead to faster turnaround times, reduced costs, and more personalized diagnostic options, all of which impact the midstream phase by streamlining test development and improving efficiency.

What are the challenges faced by laboratories in the midstream phase of the Laboratory-developed Testing Market?

Key challenges include regulatory compliance, which can delay test approval, and the need to maintain high levels of accuracy and reliability while scaling operations. Additionally, managing the cost of advanced technologies, ensuring test availability, and dealing with any disruptions in the supply chain or staffing can complicate the midstream process, making it essential for labs to stay adaptive and resilient.

What are the key distribution channels in the downstream phase of the Laboratory-developed Testing Market?

The key distribution channels include hospitals, diagnostic laboratories, clinics, and increasingly, direct-to-consumer (DTC) platforms. Many laboratories also partner with healthcare providers or pharmaceutical companies to distribute their tests, while some labs may directly market their services to consumers, especially for genetic or personalized testing.

How do healthcare providers and laboratories manage the delivery of Laboratory-developed Tests to patients?

Healthcare providers and laboratories manage the delivery through efficient lab networks, digital platforms, and patient management systems. Results are typically delivered to patients via secure online portals, through healthcare providers, or directly by the lab. Effective coordination between the test developers, medical professionals, and patients is crucial to ensure accurate and timely delivery of results.

What impact does reimbursement and pricing have on the downstream phase of the Laboratory-developed Testing Market?

Reimbursement policies significantly influence the adoption and accessibility of laboratory-developed tests. Insurance coverage and reimbursement rates can drive demand for specific tests, especially in clinical settings. Pricing pressures can also affect the affordability of tests for patients and healthcare systems, determining the commercial success of new tests.

How does customer demand affect the downstream dynamics of the Laboratory-developed Testing Market?

Customer demand, driven by factors like personalized healthcare, early disease detection, and increasing consumer health awareness, shapes the types of tests offered. As demand grows for specialized tests, laboratories must adapt their offerings to cater to niche needs, such as genetic testing or disease-specific panels, affecting both supply and marketing strategies.

What challenges do labs face in the downstream phase of the Laboratory-developed Testing Market?

Labs face challenges in ensuring the scalability of test delivery, managing customer expectations regarding result timelines, and maintaining consistent test quality. Regulatory hurdles, particularly around test approval and insurance reimbursement, can also complicate market access. Additionally, labs need to navigate increasing competition and demand for cost-effective yet high-quality diagnostic solutions.

Chapter 1, to describe Laboratory-developed Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Laboratory-developed Testing, with revenue, gross margin and global market share of Laboratory-developed Testing from 2018 to 2023.
Chapter 3, the Laboratory-developed Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Laboratory-developed Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Laboratory-developed Testing.
Chapter 13, to describe Laboratory-developed Testing research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Laboratory-developed Testing
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Laboratory-developed Testing by Type
       1.3.1 Overview: Global Laboratory-developed Testing Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Laboratory-developed Testing Consumption Value Market Share by Type in 2022
       1.3.3 Commercial Service
       1.3.4 R&D
   1.4 Global Laboratory-developed Testing Market by Application
       1.4.1 Overview: Global Laboratory-developed Testing Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Genetic Testing
       1.4.3 Oncology
       1.4.4 Infectious Disease
       1.4.5 Others
   1.5 Global Laboratory-developed Testing Market Size & Forecast
   1.6 Global Laboratory-developed Testing Market Size and Forecast by Region
       1.6.1 Global Laboratory-developed Testing Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Laboratory-developed Testing Market Size by Region, (2018-2029)
       1.6.3 North America Laboratory-developed Testing Market Size and Prospect (2018-2029)
       1.6.4 Europe Laboratory-developed Testing Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Laboratory-developed Testing Market Size and Prospect (2018-2029)
       1.6.6 South America Laboratory-developed Testing Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Laboratory-developed Testing Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Adaptive Biotechnologies Corporation
       2.1.1 Adaptive Biotechnologies Corporation Details
       2.1.2 Adaptive Biotechnologies Corporation Major Business
       2.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product and Solutions
       2.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Adaptive Biotechnologies Corporation Recent Developments and Future Plans
   2.2 Quest Diagnostics
       2.2.1 Quest Diagnostics Details
       2.2.2 Quest Diagnostics Major Business
       2.2.3 Quest Diagnostics Laboratory-developed Testing Product and Solutions
       2.2.4 Quest Diagnostics Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Quest Diagnostics Recent Developments and Future Plans
   2.3 Roche
       2.3.1 Roche Details
       2.3.2 Roche Major Business
       2.3.3 Roche Laboratory-developed Testing Product and Solutions
       2.3.4 Roche Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Roche Recent Developments and Future Plans
   2.4 Illumina
       2.4.1 Illumina Details
       2.4.2 Illumina Major Business
       2.4.3 Illumina Laboratory-developed Testing Product and Solutions
       2.4.4 Illumina Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Illumina Recent Developments and Future Plans
   2.5 Qiagen
       2.5.1 Qiagen Details
       2.5.2 Qiagen Major Business
       2.5.3 Qiagen Laboratory-developed Testing Product and Solutions
       2.5.4 Qiagen Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Qiagen Recent Developments and Future Plans
   2.6 Eurofins
       2.6.1 Eurofins Details
       2.6.2 Eurofins Major Business
       2.6.3 Eurofins Laboratory-developed Testing Product and Solutions
       2.6.4 Eurofins Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Eurofins Recent Developments and Future Plans
   2.7 Guardant Health
       2.7.1 Guardant Health Details
       2.7.2 Guardant Health Major Business
       2.7.3 Guardant Health Laboratory-developed Testing Product and Solutions
       2.7.4 Guardant Health Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Guardant Health Recent Developments and Future Plans
   2.8 Biotheranostics
       2.8.1 Biotheranostics Details
       2.8.2 Biotheranostics Major Business
       2.8.3 Biotheranostics Laboratory-developed Testing Product and Solutions
       2.8.4 Biotheranostics Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Biotheranostics Recent Developments and Future Plans
   2.9 Adaptive Biotechnologies
       2.9.1 Adaptive Biotechnologies Details
       2.9.2 Adaptive Biotechnologies Major Business
       2.9.3 Adaptive Biotechnologies Laboratory-developed Testing Product and Solutions
       2.9.4 Adaptive Biotechnologies Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Adaptive Biotechnologies Recent Developments and Future Plans
   2.10 Rosetta Genomics 
       2.10.1 Rosetta Genomics Details
       2.10.2 Rosetta Genomics Major Business
       2.10.3 Rosetta Genomics Laboratory-developed Testing Product and Solutions
       2.10.4 Rosetta Genomics Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Rosetta Genomics Recent Developments and Future Plans
   2.11 Biodesix
       2.11.1 Biodesix Details
       2.11.2 Biodesix Major Business
       2.11.3 Biodesix Laboratory-developed Testing Product and Solutions
       2.11.4 Biodesix Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Biodesix Recent Developments and Future Plans
   2.12 Helix
       2.12.1 Helix Details
       2.12.2 Helix Major Business
       2.12.3 Helix Laboratory-developed Testing Product and Solutions
       2.12.4 Helix Laboratory-developed Testing Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Helix Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Laboratory-developed Testing Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Laboratory-developed Testing by Company Revenue
       3.2.2 Top 3 Laboratory-developed Testing Players Market Share in 2022
       3.2.3 Top 6 Laboratory-developed Testing Players Market Share in 2022
   3.3 Laboratory-developed Testing Market: Overall Company Footprint Analysis
       3.3.1 Laboratory-developed Testing Market: Region Footprint
       3.3.2 Laboratory-developed Testing Market: Company Product Type Footprint
       3.3.3 Laboratory-developed Testing Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Laboratory-developed Testing Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Laboratory-developed Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Laboratory-developed Testing Consumption Value Market Share by Application (2018-2023)
   5.2 Global Laboratory-developed Testing Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Laboratory-developed Testing Consumption Value by Type (2018-2029)
   6.2 North America Laboratory-developed Testing Consumption Value by Application (2018-2029)
   6.3 North America Laboratory-developed Testing Market Size by Country
       6.3.1 North America Laboratory-developed Testing Consumption Value by Country (2018-2029)
       6.3.2 United States Laboratory-developed Testing Market Size and Forecast (2018-2029)
       6.3.3 Canada Laboratory-developed Testing Market Size and Forecast (2018-2029)
       6.3.4 Mexico Laboratory-developed Testing Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Laboratory-developed Testing Consumption Value by Type (2018-2029)
   7.2 Europe Laboratory-developed Testing Consumption Value by Application (2018-2029)
   7.3 Europe Laboratory-developed Testing Market Size by Country
       7.3.1 Europe Laboratory-developed Testing Consumption Value by Country (2018-2029)
       7.3.2 Germany Laboratory-developed Testing Market Size and Forecast (2018-2029)
       7.3.3 France Laboratory-developed Testing Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Laboratory-developed Testing Market Size and Forecast (2018-2029)
       7.3.5 Russia Laboratory-developed Testing Market Size and Forecast (2018-2029)
       7.3.6 Italy Laboratory-developed Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Laboratory-developed Testing Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Laboratory-developed Testing Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Laboratory-developed Testing Market Size by Region
       8.3.1 Asia-Pacific Laboratory-developed Testing Consumption Value by Region (2018-2029)
       8.3.2 China Laboratory-developed Testing Market Size and Forecast (2018-2029)
       8.3.3 Japan Laboratory-developed Testing Market Size and Forecast (2018-2029)
       8.3.4 South Korea Laboratory-developed Testing Market Size and Forecast (2018-2029)
       8.3.5 India Laboratory-developed Testing Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Laboratory-developed Testing Market Size and Forecast (2018-2029)
       8.3.7 Australia Laboratory-developed Testing Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Laboratory-developed Testing Consumption Value by Type (2018-2029)
   9.2 South America Laboratory-developed Testing Consumption Value by Application (2018-2029)
   9.3 South America Laboratory-developed Testing Market Size by Country
       9.3.1 South America Laboratory-developed Testing Consumption Value by Country (2018-2029)
       9.3.2 Brazil Laboratory-developed Testing Market Size and Forecast (2018-2029)
       9.3.3 Argentina Laboratory-developed Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Laboratory-developed Testing Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Laboratory-developed Testing Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Laboratory-developed Testing Market Size by Country
       10.3.1 Middle East & Africa Laboratory-developed Testing Consumption Value by Country (2018-2029)
       10.3.2 Turkey Laboratory-developed Testing Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Laboratory-developed Testing Market Size and Forecast (2018-2029)
       10.3.4 UAE Laboratory-developed Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Laboratory-developed Testing Market Drivers
   11.2 Laboratory-developed Testing Market Restraints
   11.3 Laboratory-developed Testing Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Laboratory-developed Testing Industry Chain
   12.2 Laboratory-developed Testing Upstream Analysis
   12.3 Laboratory-developed Testing Midstream Analysis
   12.4 Laboratory-developed Testing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer
 

List of Tables

   Table 1. Global Laboratory-developed Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Laboratory-developed Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Laboratory-developed Testing Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Laboratory-developed Testing Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Adaptive Biotechnologies Corporation Company Information, Head Office, and Major Competitors
   Table 6. Adaptive Biotechnologies Corporation Major Business
   Table 7. Adaptive Biotechnologies Corporation Laboratory-developed Testing Product and Solutions
   Table 8. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Adaptive Biotechnologies Corporation Recent Developments and Future Plans
   Table 10. Quest Diagnostics Company Information, Head Office, and Major Competitors
   Table 11. Quest Diagnostics Major Business
   Table 12. Quest Diagnostics Laboratory-developed Testing Product and Solutions
   Table 13. Quest Diagnostics Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Quest Diagnostics Recent Developments and Future Plans
   Table 15. Roche Company Information, Head Office, and Major Competitors
   Table 16. Roche Major Business
   Table 17. Roche Laboratory-developed Testing Product and Solutions
   Table 18. Roche Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Roche Recent Developments and Future Plans
   Table 20. Illumina Company Information, Head Office, and Major Competitors
   Table 21. Illumina Major Business
   Table 22. Illumina Laboratory-developed Testing Product and Solutions
   Table 23. Illumina Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Illumina Recent Developments and Future Plans
   Table 25. Qiagen Company Information, Head Office, and Major Competitors
   Table 26. Qiagen Major Business
   Table 27. Qiagen Laboratory-developed Testing Product and Solutions
   Table 28. Qiagen Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Qiagen Recent Developments and Future Plans
   Table 30. Eurofins Company Information, Head Office, and Major Competitors
   Table 31. Eurofins Major Business
   Table 32. Eurofins Laboratory-developed Testing Product and Solutions
   Table 33. Eurofins Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Eurofins Recent Developments and Future Plans
   Table 35. Guardant Health Company Information, Head Office, and Major Competitors
   Table 36. Guardant Health Major Business
   Table 37. Guardant Health Laboratory-developed Testing Product and Solutions
   Table 38. Guardant Health Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Guardant Health Recent Developments and Future Plans
   Table 40. Biotheranostics Company Information, Head Office, and Major Competitors
   Table 41. Biotheranostics Major Business
   Table 42. Biotheranostics Laboratory-developed Testing Product and Solutions
   Table 43. Biotheranostics Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Biotheranostics Recent Developments and Future Plans
   Table 45. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
   Table 46. Adaptive Biotechnologies Major Business
   Table 47. Adaptive Biotechnologies Laboratory-developed Testing Product and Solutions
   Table 48. Adaptive Biotechnologies Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. Adaptive Biotechnologies Recent Developments and Future Plans
   Table 50. Rosetta Genomics Company Information, Head Office, and Major Competitors
   Table 51. Rosetta Genomics Major Business
   Table 52. Rosetta Genomics Laboratory-developed Testing Product and Solutions
   Table 53. Rosetta Genomics Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Rosetta Genomics Recent Developments and Future Plans
   Table 55. Biodesix Company Information, Head Office, and Major Competitors
   Table 56. Biodesix Major Business
   Table 57. Biodesix Laboratory-developed Testing Product and Solutions
   Table 58. Biodesix Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Biodesix Recent Developments and Future Plans
   Table 60. Helix Company Information, Head Office, and Major Competitors
   Table 61. Helix Major Business
   Table 62. Helix Laboratory-developed Testing Product and Solutions
   Table 63. Helix Laboratory-developed Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Helix Recent Developments and Future Plans
   Table 65. Global Laboratory-developed Testing Revenue (USD Million) by Players (2018-2023)
   Table 66. Global Laboratory-developed Testing Revenue Share by Players (2018-2023)
   Table 67. Breakdown of Laboratory-developed Testing by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 68. Market Position of Players in Laboratory-developed Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 69. Head Office of Key Laboratory-developed Testing Players
   Table 70. Laboratory-developed Testing Market: Company Product Type Footprint
   Table 71. Laboratory-developed Testing Market: Company Product Application Footprint
   Table 72. Laboratory-developed Testing New Market Entrants and Barriers to Market Entry
   Table 73. Laboratory-developed Testing Mergers, Acquisition, Agreements, and Collaborations
   Table 74. Global Laboratory-developed Testing Consumption Value (USD Million) by Type (2018-2023)
   Table 75. Global Laboratory-developed Testing Consumption Value Share by Type (2018-2023)
   Table 76. Global Laboratory-developed Testing Consumption Value Forecast by Type (2024-2029)
   Table 77. Global Laboratory-developed Testing Consumption Value by Application (2018-2023)
   Table 78. Global Laboratory-developed Testing Consumption Value Forecast by Application (2024-2029)
   Table 79. North America Laboratory-developed Testing Consumption Value by Type (2018-2023) & (USD Million)
   Table 80. North America Laboratory-developed Testing Consumption Value by Type (2024-2029) & (USD Million)
   Table 81. North America Laboratory-developed Testing Consumption Value by Application (2018-2023) & (USD Million)
   Table 82. North America Laboratory-developed Testing Consumption Value by Application (2024-2029) & (USD Million)
   Table 83. North America Laboratory-developed Testing Consumption Value by Country (2018-2023) & (USD Million)
   Table 84. North America Laboratory-developed Testing Consumption Value by Country (2024-2029) & (USD Million)
   Table 85. Europe Laboratory-developed Testing Consumption Value by Type (2018-2023) & (USD Million)
   Table 86. Europe Laboratory-developed Testing Consumption Value by Type (2024-2029) & (USD Million)
   Table 87. Europe Laboratory-developed Testing Consumption Value by Application (2018-2023) & (USD Million)
   Table 88. Europe Laboratory-developed Testing Consumption Value by Application (2024-2029) & (USD Million)
   Table 89. Europe Laboratory-developed Testing Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Laboratory-developed Testing Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Laboratory-developed Testing Consumption Value by Type (2018-2023) & (USD Million)
   Table 92. Asia-Pacific Laboratory-developed Testing Consumption Value by Type (2024-2029) & (USD Million)
   Table 93. Asia-Pacific Laboratory-developed Testing Consumption Value by Application (2018-2023) & (USD Million)
   Table 94. Asia-Pacific Laboratory-developed Testing Consumption Value by Application (2024-2029) & (USD Million)
   Table 95. Asia-Pacific Laboratory-developed Testing Consumption Value by Region (2018-2023) & (USD Million)
   Table 96. Asia-Pacific Laboratory-developed Testing Consumption Value by Region (2024-2029) & (USD Million)
   Table 97. South America Laboratory-developed Testing Consumption Value by Type (2018-2023) & (USD Million)
   Table 98. South America Laboratory-developed Testing Consumption Value by Type (2024-2029) & (USD Million)
   Table 99. South America Laboratory-developed Testing Consumption Value by Application (2018-2023) & (USD Million)
   Table 100. South America Laboratory-developed Testing Consumption Value by Application (2024-2029) & (USD Million)
   Table 101. South America Laboratory-developed Testing Consumption Value by Country (2018-2023) & (USD Million)
   Table 102. South America Laboratory-developed Testing Consumption Value by Country (2024-2029) & (USD Million)
   Table 103. Middle East & Africa Laboratory-developed Testing Consumption Value by Type (2018-2023) & (USD Million)
   Table 104. Middle East & Africa Laboratory-developed Testing Consumption Value by Type (2024-2029) & (USD Million)
   Table 105. Middle East & Africa Laboratory-developed Testing Consumption Value by Application (2018-2023) & (USD Million)
   Table 106. Middle East & Africa Laboratory-developed Testing Consumption Value by Application (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Laboratory-developed Testing Consumption Value by Country (2018-2023) & (USD Million)
   Table 108. Middle East & Africa Laboratory-developed Testing Consumption Value by Country (2024-2029) & (USD Million)
   Table 109. Laboratory-developed Testing Raw Material
   Table 110. Key Suppliers of Laboratory-developed Testing Raw Materials

List of Figures

   Figure 1. Laboratory-developed Testing Picture
   Figure 2. Global Laboratory-developed Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Laboratory-developed Testing Consumption Value Market Share by Type in 2022
   Figure 4. Commercial Service
   Figure 5. R&D
   Figure 6. Global Laboratory-developed Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 7. Laboratory-developed Testing Consumption Value Market Share by Application in 2022
   Figure 8. Genetic Testing Picture
   Figure 9. Oncology Picture
   Figure 10. Infectious Disease Picture
   Figure 11. Others Picture
   Figure 12. Global Laboratory-developed Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Laboratory-developed Testing Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Market Laboratory-developed Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 15. Global Laboratory-developed Testing Consumption Value Market Share by Region (2018-2029)
   Figure 16. Global Laboratory-developed Testing Consumption Value Market Share by Region in 2022
   Figure 17. North America Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 18. Europe Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 19. Asia-Pacific Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 20. South America Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 21. Middle East and Africa Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 22. Global Laboratory-developed Testing Revenue Share by Players in 2022
   Figure 23. Laboratory-developed Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 24. Global Top 3 Players Laboratory-developed Testing Market Share in 2022
   Figure 25. Global Top 6 Players Laboratory-developed Testing Market Share in 2022
   Figure 26. Global Laboratory-developed Testing Consumption Value Share by Type (2018-2023)
   Figure 27. Global Laboratory-developed Testing Market Share Forecast by Type (2024-2029)
   Figure 28. Global Laboratory-developed Testing Consumption Value Share by Application (2018-2023)
   Figure 29. Global Laboratory-developed Testing Market Share Forecast by Application (2024-2029)
   Figure 30. North America Laboratory-developed Testing Consumption Value Market Share by Type (2018-2029)
   Figure 31. North America Laboratory-developed Testing Consumption Value Market Share by Application (2018-2029)
   Figure 32. North America Laboratory-developed Testing Consumption Value Market Share by Country (2018-2029)
   Figure 33. United States Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 34. Canada Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 35. Mexico Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 36. Europe Laboratory-developed Testing Consumption Value Market Share by Type (2018-2029)
   Figure 37. Europe Laboratory-developed Testing Consumption Value Market Share by Application (2018-2029)
   Figure 38. Europe Laboratory-developed Testing Consumption Value Market Share by Country (2018-2029)
   Figure 39. Germany Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 40. France Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 41. United Kingdom Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 42. Russia Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 43. Italy Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 44. Asia-Pacific Laboratory-developed Testing Consumption Value Market Share by Type (2018-2029)
   Figure 45. Asia-Pacific Laboratory-developed Testing Consumption Value Market Share by Application (2018-2029)
   Figure 46. Asia-Pacific Laboratory-developed Testing Consumption Value Market Share by Region (2018-2029)
   Figure 47. China Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 48. Japan Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 49. South Korea Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 50. India Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 51. Southeast Asia Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 52. Australia Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 53. South America Laboratory-developed Testing Consumption Value Market Share by Type (2018-2029)
   Figure 54. South America Laboratory-developed Testing Consumption Value Market Share by Application (2018-2029)
   Figure 55. South America Laboratory-developed Testing Consumption Value Market Share by Country (2018-2029)
   Figure 56. Brazil Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 57. Argentina Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 58. Middle East and Africa Laboratory-developed Testing Consumption Value Market Share by Type (2018-2029)
   Figure 59. Middle East and Africa Laboratory-developed Testing Consumption Value Market Share by Application (2018-2029)
   Figure 60. Middle East and Africa Laboratory-developed Testing Consumption Value Market Share by Country (2018-2029)
   Figure 61. Turkey Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 62. Saudi Arabia Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 63. UAE Laboratory-developed Testing Consumption Value (2018-2029) & (USD Million)
   Figure 64. Laboratory-developed Testing Market Drivers
   Figure 65. Laboratory-developed Testing Market Restraints
   Figure 66. Laboratory-developed Testing Market Trends
   Figure 67. Porters Five Forces Analysis
   Figure 68. Manufacturing Cost Structure Analysis of Laboratory-developed Testing in 2022
   Figure 69. Manufacturing Process Analysis of Laboratory-developed Testing
   Figure 70. Laboratory-developed Testing Industrial Chain
   Figure 71. Methodology
   Figure 72. Research Process and Data Source